Archives
-
Flavopiridol Workflows for CDK and ER-Stress Studies
2026-08-18
Flavopiridol, also known as L868275, provides a practical way to connect pan-CDK inhibition with cell-cycle arrest, apoptosis, and transcriptional readouts. This guide translates intestinal endoplasmic-reticulum-stress findings into controlled assay designs for cancer research while clearly separating established evidence from exploratory applications.
-
Targeted SPP1 Inhibition in Tumor Myeloid Cells
2026-08-17
The reference study identifies a phenotypic small-molecule strategy for reducing SPP1 expression in tumor-associated macrophages and integrates lead compounds into a TAM-avid nanodelivery system. Its lead compound, CANDI460, decreased SPP1 in vitro and in vivo and produced tumor remissions in multiple murine models, providing a framework for myeloid-directed cancer therapy.
-
GRE, CREB/MITF, and Melanogenesis Control
2026-08-17
The reference study shows that a combined preparation of glabridin, resveratrol, and ellagic acid (GRE) can integrate anti-melanogenic, antioxidant, and anti-inflammatory effects in complementary cellular assays. Its mechanistic contribution is the linking of reduced melanin and tyrosinase activity to suppression of CREB phosphorylation and MITF-associated gene and protein expression.
-
5-Methyl-CTP for Robust mRNA Workflows
2026-08-16
Learn how to integrate 5-Methyl-CTP into in vitro transcription, from molar substitution screens to RNA quality checks and delivery-focused assays. The workflow also shows how chemically optimized mRNA can complement the OMV “Plug-and-Display” strategy reported for personalized tumor vaccination.
-
FerroOrange Maps Fe²⁺ in Asthma Ferroptosis
2026-08-15
FerroOrange, a Fe²⁺ fluorescent probe, helps connect intracellular iron detection with PM2.5-driven macrophage ferroptosis. This article explains how to use its live-cell signal to distinguish iron accumulation from downstream death pathways and improve mechanistic assay design.
-
Levofloxacin: Applied Assays and Workflow Guide
2026-08-14
Levofloxacin supports both bacterial DNA replication studies and carefully controlled bone-cell assays, making it useful for research that connects antimicrobial mechanism with tissue biology. This guide covers stock preparation, assay design, comparative interpretation, and troubleshooting for osteoblast, chondrocyte, and bacterial workflows.
-
PKH26 Red Fluorescent Cell Linker Kit Guide
2026-08-14
The PKH26 Red Fluorescent Cell Linker Kit provides membrane-associated red fluorescent labeling for cell tracing and proliferation studies when a persistent, low-background signal is needed. It is intended for cell membrane lipid-region labeling in vitro or in vivo, not for intracellular targets or non-membrane labeling.
-
Toremifene Workflows for Prostate Cancer Research
2026-08-13
Build reproducible Toremifene experiments that connect estrogen receptor modulation with growth, migration, invasion, and calcium-signaling readouts. This workflow uses the compound as a pathway probe while clearly separating established findings from hypothesis-generating applications around the STIM1 axis.
-
Etoposide (VP-16) Workflows for DNA Damage Assays
2026-08-13
Etoposide (VP-16) provides a controllable way to generate topoisomerase II-linked DNA double-strand breaks, making it useful for cytotoxicity, repair, and apoptosis studies. This practical guide connects concentration selection, assay timing, formulation, and troubleshooting with the mechanistic insights of a DNA-PKcs genome-integrity study.
-
Sulfaphenazole-Derived Sulfonamides Against M. tuberculosis
2026-08-12
Chen and colleagues optimized sulfaphenazole-derived sulfonamides to retain antimycobacterial activity while reducing CYP2C9 inhibition, a property relevant to drug–drug interaction risk. Compound 10d was the leading example, combining an MIC of 5.69 μg/mL against M. tuberculosis H37Rv with CYP2C9 inhibition weaker than 10 μM.
-
Chlorpromazine HCl Beyond Dopamine
2026-08-12
Chlorpromazine HCl is more than a classic dopamine receptor antagonist: it is a mechanistic probe for connecting receptor pharmacology, synaptic physiology, and emerging host-directed antibacterial research. This article outlines how translational teams can use the compound to separate established neuropharmacology from testable cross-domain hypotheses.
-
Lisinopril Dihydrate in ACE Research Workflows
2026-08-11
Lisinopril dihydrate provides a water-compatible, long-acting ACE inhibitor platform for connecting biochemical target engagement with vascular, cardiac, and renal phenotypes. This workflow-focused guide covers assay design, disease-model applications, formulation, controls, and troubleshooting for reproducible translational research.
-
Guanabenz Acetate in GPCR and Stress Assays
2026-08-11
Guanabenz Acetate provides a practical way to probe α2-adrenergic receptor signaling while preserving a clear path to subtype-aware cell experiments. This guide translates findings on SARS-CoV-2 nucleocapsid, GADD34, IRF3, and atypical stress-granule foci into controlled assay workflows without overstating an unproven antiviral effect.
-
Glycogen Colorimetric Assay Kit II for Circadian Biology
2026-08-10
Discover how the Glycogen Colorimetric Assay Kit II supports mechanistic glycogen measurement in circadian exercise and metabolic studies. This guide connects assay chemistry with sampling design, interference control, and interpretation of tissue-specific adaptation.
-
Thermal-Protective Hydrogel for Tumor Ablation
2026-08-09
The reference study presents MR@CaP@HA, an injectable hydrogel that combines local thermal insulation with pH- and GSH-responsive delivery of mitoxantrone and Resiquimod. By linking procedural protection to chemo-immunomodulation, the platform improves residual tumor control while stimulating dendritic cells and macrophage reprogramming.